News
5don MSN
Baron Funds, an investment management company, released its “Baron Health Care Fund” second-quarter 2025 investor letter. A ...
Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced an expanded ...
4d
GlobalData on MSNExact Sciences expands partnership with Humana to improve colorectal cancer screeningThe Cologuard Plus test is being offered as an in-network service to eligible Humana Medicare Advantage members.
Easy at-home tests for colon cancer, including FIT and Cologuard, offer alternatives to traditional colonoscopies for early ...
Analysts anticipate Exact Sciences to report an earnings per share (EPS) of $0.02. Anticipation surrounds Exact Sciences's ...
LaMontagne will lead the commercial rollout of the company’s groundbreaking early-stage cancer detection test, Certitude.
The Escape Pod’s Lil Jon remix is Campaign of the Year, Health Care, Gold, in the 2025 Small Agency Awards.
Jan. 16-18 _ Mitsubishi Electric Championship at Hualalai (Ernie Els) April 4-6 _ James Hardie Pro-Football Hall of Fame Invitational (Angel Cabrera) Aug. 8-10 _ Boeing Classic, Snoqualmie, Wash. Aug.
University research in Wisconsin led to $500 million Third Wave business, screening tests for cancer, including Cologuard ...
James Van Der Beek was diagnosed with colon cancer in 2023. He hopes more people will get screened earlier with the new ...
7d
Zacks Investment Research on MSNTempus AI Taps Growing ICI Market With New xM AssayTempus AI, Inc. TEM recently introduced xM for treatment response monitoring (TRM), a liquid biopsy assay. It is designed to detect molecular response to immune-checkpoint inhibitor (ICI) therapy in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results